Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

20 Apr, 2017, 10:13 ET Thought-leaders in CMA Discuss the Latest Innovations in the Dietary Management of Allergy March

The World Allergy Organization estimates that 1.9% to 4.9% of children live with cow's milk allergy (CMA), which positions this disorder among...


20 Apr, 2017, 09:52 ET MGC Diagnostics Announces Clinical Study to Evaluate the Diagnostic Accuracy of the Forced Oscillatory Technique (FOT) to Detect Lung Function Abnormalities

MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today announced a new clinical study collaboration with Restech...


20 Apr, 2017, 09:15 ET BioPharmX Completes Last Subject Visit in its Phase 2b Trial of BPX-01, Expects to Report Topline Results First Half of May 2017

BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, announced the last...


20 Apr, 2017, 09:10 ET Nektar Therapeutics to Host Analyst & Investor Event at 2017 ASCO Annual Meeting

Nektar Therapeutics (Nasdaq: NKTR) today announced that it will host an analyst and investor event with clinical investigators on Saturday, June 3,...


20 Apr, 2017, 09:00 ET IriSys Contract with NCI for Manufacturing Clinical Trial Materials is Doubled in Value

IriSys, LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services, today announced that it was...


20 Apr, 2017, 09:00 ET Gamida Cell Announces Publication of Positive Clinical Outcomes from NiCord-Transplanted Patients in the Journal of Biology of Blood and Marrow Transplantation

Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today the publication of...


20 Apr, 2017, 09:00 ET Allergan Partners with TARGET PharmaSolutions to Advance NASH Research

Allergan, a leading global biopharmaceutical company, announced today that it will collaborate with TARGET PharmaSolutions, a clinical data company...


20 Apr, 2017, 08:50 ET Phase 1/2 Clinical Trial of Agenus' anti-PD-1 Antibody Begins

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies and cancer vaccines, today announced...


20 Apr, 2017, 08:45 ET Prominent neurosurgeon and 17-year survivor of brain tumors encourage support for brain tumor research as National Brain Tumor Awareness Month approaches

More than 16,000 U.S. residents die from one of 120 different forms of brain tumors each year. This is a statistic that concerns a highly regarded...


20 Apr, 2017, 08:30 ET New Studies Show Storing Respiratory Devices in Plastic Bags Causes Infections in Hospitals

Infection Prevention Products Inc. has announced today that Hospitals are causing infections by using Plastic Bags to store a patient's reusable...


20 Apr, 2017, 08:00 ET Researchers to Present Updated Clinical Data on Intraoperative Radiation Therapy Using the Xoft System at American Brachytherapy Society (ABS) Annual Meeting

(#T1) -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early...


20 Apr, 2017, 07:30 ET AbbVie's Investigational, Pan-Genotypic, Ribavirin-free Regimen of Glecaprevir/Pibrentasvir (G/P) Achieved 99 Percent SVR(12) Rate in Chronic Hepatitis C Patients with Compensated Cirrhosis

AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that 99 percent (n=145/146) of chronic hepatitis C virus (HCV) infected...


20 Apr, 2017, 03:00 ET Eyevensys Receives Approval From the UK Medicines and Healthcare Products Regulatory Agency to Advance its EyeCET Platform Into Clinical Development

Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables...


20 Apr, 2017, 02:42 ET NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical results demonstrating...


19 Apr, 2017, 19:51 ET First patients at Vanderbilt University Medical Center implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD)

Vanderbilt University Medical Center (VUMC) and EndoStim, Inc., announced that the first patients in Nashville, Tennesse have been implanted with...


19 Apr, 2017, 17:50 ET AbbVie Announces Topline Results from Two Phase 3 Studies Investigating Veliparib in Combination with Chemotherapy for the Treatment of Patients with Advanced or Metastatic Squamous Non-Small Cell Lung Cancer and Early-Stage Triple-Negative Breast Cancer

AbbVie, a global biopharmaceutical company, today announced that two Phase 3 studies evaluating veliparib, an investigational, oral poly (adenosine...


19 Apr, 2017, 17:05 ET NIH study in NEJM shows Novartis drug eltrombopag as first-line therapy with standard treatment improves responses in severe aplastic anemia

Novartis today announced the publication of a study conducted by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes...


19 Apr, 2017, 16:30 ET Multi-Center Clinical Study Confirms Decreased Levels of Procalcitonin as an Independent Predictor of Mortality in Patients with Severe Sepsis and Septic Shock

Thermo Fisher Scientific Inc. today announced that results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) Study have been published...


19 Apr, 2017, 14:20 ET Las Palmas Medical Center First Site in the World To Host Clinical Trial for Fluorescent Imaging Agent Aimed to Prevent Ureter Injuries During Surgery

Las Palmas Medical Center is the first and currently only site in the world to enroll patients in a clinical trial for a fluorescent imaging agent,...


19 Apr, 2017, 14:00 ET Therapeutic Goods Administration Approves AFSTYLA® - CSL Behring's Novel Recombinant Haemophilia A Treatment

Global biotherapeutics leader, CSL Behring today announced that the Australian Therapeutic Goods Administration (TGA) has approved AFSTYLA®...


19 Apr, 2017, 12:14 ET Cannabis-based Medicine May Cut Seizures in Half for Those with Tough-to-treat Epilepsy

Taking cannabidiol may cut seizures in half for some children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy, according...


19 Apr, 2017, 11:08 ET First Published Clinical Study Successfully Uses Precision Medicine To Predict Prescription Opioid Abuse

As a Bronze Sponsor of the National Rx Drug Abuse and Heroin Summit, Proove® Biosciences, Inc. announces the first-ever peer-reviewed published...


19 Apr, 2017, 11:05 ET First-of-Its-Kind "SMILE" Vision Surgery Debuts Statewide in Nashville April 21st -- Minimally Invasive New 3D Laser Vision Procedure Being Performed by Nashville's Renowned Dr. Ming Wang

The first major advance in LASIK technology in 20 years, the SMILE procedure, will be performed in Nashville this Friday, April 21, 2017 at Wang...


19 Apr, 2017, 10:36 ET Finding Solutions that Help a Unique Monoclonal Antibody Advance the Fight Against Metastatic Breast Cancer

An important, seminal study was recently published in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal (Revskaya, E, et al. Vol...


19 Apr, 2017, 10:29 ET Center Point Clinical Services Announces New Consensus Guidelines Drafted by KOL Industry Leaders for the Modern Clinical Study Including the Siteless CRO and In-home Clinical Trial

Center Point Clinical Services, creator of the world's first Siteless CRO platform, announced today new consensus guidelines drafted by Key...


Most Viewed